Camurus (NASDAQ STO: CAMX) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's resubmission of the New Drug Application (NDA) for Oclaiz™ (CAM2029), ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Apply to become a Senior Planet sponsored athlete to motivate ...

Self-administered injectable contraceptives have been available in the United States for more than two decades, yet a new ...

Record-high EXPAREL sales driven by volume growth of 7 percent, marking strongest fourth quarter performance in three ...

A nanomaterial based on a platform developed by Professor Samuel Stupp crosses the blood-brain barrier and targets harmful ...

Jennette McCurdy may have undergone the delicate and very involved procedure of freezing her eggs - but that doesn't make her ...

Novo Nordisk is my top opportunity for 2026, driven by multiple catalysts and a compelling valuation. The Wegovy pill's FDA ...

CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening ...

D spent a decade recovering from an addiction that started when he fell off a ladder, got injured and was prescribed opioid pain pills.

Preliminary Preclinical Data Demonstrates In Vivo Proof-of-Concept for Novel Diabetes Gene Therapy in Type 2 Diabetic Non-Human Primates GPX-002 Rejuvenated Exhausted ...

Niagen Bioscience continues to see improving demand for Tru Niagen, strengthening cash generation, and a debt-free balance ...

Alex Terrible addresses critics in a candid new statement, rejecting his "poser tough guy" label and opening up about ...